NasdaqCM - Nasdaq Real Time Price USD

Jin Medical International Ltd. (ZJYL)

Compare
2.5000 -0.0400 (-1.57%)
At close: October 15 at 4:00 PM EDT
2.6000 +0.10 (+4.00%)
Pre-Market: 8:00 AM EDT
Loading Chart for ZJYL
DELL
  • Previous Close 2.5400
  • Open 2.6600
  • Bid 2.0800 x 200
  • Ask 3.1600 x 200
  • Day's Range 2.4200 - 2.9050
  • 52 Week Range 0.4013 - 25.4935
  • Volume 2,026,697
  • Avg. Volume 239,671
  • Market Cap (intraday) 391.368M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 125.00
  • EPS (TTM) 0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

www.zhjmedical.com

245

Full Time Employees

September 30

Fiscal Year Ends

Recent News: ZJYL

View More

Performance Overview: ZJYL

Trailing total returns as of 10/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ZJYL
79.84%
S&P 500
21.92%

1-Year Return

ZJYL
163.71%
S&P 500
34.37%

3-Year Return

ZJYL
525.00%
S&P 500
46.43%

5-Year Return

ZJYL
525.00%
S&P 500
46.43%

Compare To: ZJYL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZJYL

View More

Valuation Measures

Annual
As of 10/15/2024
  • Market Cap

    391.37M

  • Enterprise Value

    375.33M

  • Trailing P/E

    125.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    19.34

  • Price/Book (mrq)

    14.91

  • Enterprise Value/Revenue

    18.65

  • Enterprise Value/EBITDA

    144.10

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.44%

  • Return on Assets (ttm)

    4.03%

  • Return on Equity (ttm)

    11.33%

  • Revenue (ttm)

    20.13M

  • Net Income Avi to Common (ttm)

    2.91M

  • Diluted EPS (ttm)

    0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    25.99M

  • Total Debt/Equity (mrq)

    38.04%

  • Levered Free Cash Flow (ttm)

    3.12M

Research Analysis: ZJYL

View More

Company Insights: ZJYL

Research Reports: ZJYL

View More

People Also Watch